Edison report, $1.16 target. Good luck holders, I hope the trial goes well: https://www.edisoninvestmentresearch.com/?ACT=18&ID=21842&LANG=
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025